Benzinga's Top Ratings Upgrades, Downgrades For June 20, 2023

Upgrades

Tudor Pickering upgraded the previous rating for EQT Corp (NYSE:EQT) from Hold to Buy. EQT earned $1.70 in the first quarter, compared to $0.81 in the year-ago quarter. At the moment, the stock has a 52-week-high of $51.95 and a 52-week-low of $28.11. EQT closed at $39.64 at the end of the last trading period.

According to Wells Fargo, the prior rating for Ball Corp (NYSE:BALL) was changed from Underweight to Equal-Weight. Ball earned $0.69 in the first quarter, compared to $1.37 in the year-ago quarter. At the moment, the stock has a 52-week-high of $74.34 and a 52-week-low of $46.00. Ball closed at $58.43 at the end of the last trading period.

Credit Suisse upgraded the previous rating for Studio City International Holdings Ltd (NYSE:MSC) from Neutral to Outperform. In the first quarter, Studio City Intl Hldgs showed an EPS of $0.17, compared to $0.54 from the year-ago quarter.

JMP Securities upgraded the previous rating for EPR Properties (NYSE:EPR) from Market Perform to Market Outperform. For the first quarter, EPR Props had an EPS of $1.26, compared to year-ago quarter EPS of $1.10. The stock has a 52-week-high of $55.90 and a 52-week-low of $33.92. At the end of the last trading period, EPR Props closed at $45.80.

See all analyst ratings upgrades.

Downgrades

For Nike Inc (NYSE:NKE), OTR Global downgraded the previous rating of Positive to Mixed. Nike earned $0.79 in the third quarter, compared to $0.87 in the year-ago quarter. At the moment, the stock has a 52-week-high of $131.31 and a 52-week-low of $82.24. Nike closed at $113.59 at the end of the last trading period.

For Portland General Electric Co (NYSE:POR), Guggenheim downgraded the previous rating of Buy to Neutral. Portland Gen Electric earned $0.80 in the first quarter, compared to $0.67 in the year-ago quarter. The stock has a 52-week-high of $56.26 and a 52-week-low of $41.68. At the end of the last trading period, Portland Gen Electric closed at $48.67.

Wedbush downgraded the previous rating for Surface Oncology Inc (NASDAQ:SURF) from Outperform to Neutral. Surface Oncology earned $0.33 in the first quarter, compared to $0.13 in the year-ago quarter. At the moment, the stock has a 52-week-high of $2.14 and a 52-week-low of $0.56. Surface Oncology closed at $0.79 at the end of the last trading period.

According to RBC Capital, the prior rating for Abcam PLC (NASDAQ:ABCM) was changed from Outperform to Sector Perform. NoneThe current stock performance of Abcam shows a 52-week-high of $22.54 and a 52-week-low of $12.48. Moreover, at the end of the last trading period, the closing price was at $22.31.

See all analyst ratings downgrades.

Initiations

With a Buy rating, ThinkEquity initiated coverage on G Medical Innovations Holdings Ltd (NASDAQ:GMVD). The price target seems to have been set at $4.00 for G Medical Innovations. NoneThe stock has a 52-week-high of $41.30 and a 52-week-low of $0.34. At the end of the last trading period, G Medical Innovations closed at $0.38.

Roth MKM initiated coverage on Tigo Energy Inc (NASDAQ:TYGO) with a Buy rating. The price target for Tigo Energy is set to $21.00. At the moment, the stock has a 52-week-high of $27.00 and a 52-week-low of $9.69. Tigo Energy closed at $16.20 at the end of the last trading period.

Craig-Hallum initiated coverage on Tigo Energy Inc (NASDAQ:TYGO) with a Buy rating. The price target for Tigo Energy is set to $28.00. At the moment, the stock has a 52-week-high of $27.00 and a 52-week-low of $9.69. Tigo Energy closed at $16.20 at the end of the last trading period.

Wells Fargo initiated coverage on Atmus Filtration Technologies Inc (NYSE:ATMU) with an Overweight rating. The price target for Atmus Filtration Techs is set to $24.00. The stock has a 52-week-high of $22.50 and a 52-week-low of $19.10. At the end of the last trading period, Atmus Filtration Techs closed at $19.52.

BMO Capital initiated coverage on Bravo Multinational Inc (OTC:BRVO) with an Outperform rating. The price target for Bravo Multinational is set to $5.50.

EF Hutton initiated coverage on CalciMedica Inc (NASDAQ:CALC) with a Buy rating. The price target for CalciMedica is set to $17.00.

Morgan Stanley initiated coverage on Chubb Ltd (NYSE:CB) with a Equal-Weight rating. The price target for Chubb is set to $192.00. For the first quarter, Chubb had an EPS of $4.41, compared to year-ago quarter EPS of $3.83. The stock has a 52-week-high of $231.37 and a 52-week-low of $173.88. At the end of the last trading period, Chubb closed at $194.94.

Morgan Stanley initiated coverage on Aon PLC (NYSE:AON) with a Equal-Weight rating. The price target for Aon is set to $340.00. Aon earned $5.17 in the first quarter, compared to $4.83 in the year-ago quarter. The stock has a 52-week-high of $338.27 and a 52-week-low of $246.51. At the end of the last trading period, Aon closed at $329.38.

For Confluent Inc (NASDAQ:CFLT), Wolfe Research initiated coverage, by setting the current rating at Peer Perform. Confluent earned $0.09 in the first quarter, compared to $0.19 in the year-ago quarter. At the moment, the stock has a 52-week-high of $37.51 and a 52-week-low of $16.60. Confluent closed at $34.69 at the end of the last trading period.

For GitLab Inc (NASDAQ:GTLB), Wolfe Research initiated coverage, by setting the current rating at Peer Perform. In the first quarter, GitLab showed an EPS of $0.06, compared to $0.18 from the year-ago quarter. At the moment, the stock has a 52-week-high of $70.91 and a 52-week-low of $26.24. GitLab closed at $51.24 at the end of the last trading period.

With an Outperform rating, Baird initiated coverage on Atmus Filtration Technologies Inc (NYSE:ATMU). The price target seems to have been set at $24.00 for Atmus Filtration Techs. At the moment, the stock has a 52-week-high of $22.50 and a 52-week-low of $19.10. Atmus Filtration Techs closed at $19.52 at the end of the last trading period.

HC Wainwright & Co. initiated coverage on Calliditas Therapeutics AB (NASDAQ:CALT) with a Buy rating. The price target for Calliditas Therapeutics is set to $60.00. Calliditas Therapeutics earned $0.33 in the first quarter, compared to $0.85 in the year-ago quarter.

Goldman Sachs initiated coverage on Atmus Filtration Technologies Inc (NYSE:ATMU) with a Buy rating. The price target for Atmus Filtration Techs is set to $30.00. The stock has a 52-week-high of $22.50 and a 52-week-low of $19.10. At the end of the last trading period, Atmus Filtration Techs closed at $19.52.

JP Morgan initiated coverage on Atmus Filtration Technologies Inc (NYSE:ATMU) with an Overweight rating. The price target for Atmus Filtration Techs is set to $28.00. The stock has a 52-week-high of $22.50 and a 52-week-low of $19.10. At the end of the last trading period, Atmus Filtration Techs closed at $19.52.

See all analyst ratings initiations.

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.